S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1175 Events
🤖 AI Analyzed
Recent
📄 Page 40 of 98
BCB BANCORP INC
8-K January 16, 2026

Key Highlights

  • BCB Bancorp Inc. announced $31.5 million in pre-tax charges for Q4 2025, materia...
  • The charges include an additional $15.1 million write-down on a cannabis-linked ...
  • Management states the bank's financial position provides sufficient capital to a...
Read Analysis
🤖 AI Generated
TransDigm Group INC
8-K January 16, 2026

Key Highlights

  • Strategic acquisition of Jet Parts Engineering (JPE) and Victor Sierra Aviation ...
  • Reinforces TransDigm's long-standing strategy of buying businesses with unique, ...
  • Acquired entities specialize in OEM-alternative and PMA parts, generating most r...
Read Analysis
🤖 AI Generated
B&G Foods, Inc.
8-K January 16, 2026

Key Highlights

  • B&G Foods is expanding its portfolio with a major acquisition in the growing bro...
  • Acquiring College Inn and Kitchen Basics, well-established, leading brands, for ...
  • The acquisition aligns with B&G Foods' strategy to strengthen its shelf-stable, ...
Read Analysis
🤖 AI Generated
MOSAIC CO
8-K January 16, 2026

Key Highlights

  • Mosaic released preliminary Q4 and full-year 2025 financial results, providing a...
  • These preliminary figures serve as an early indicator of the company's financial...
  • The early disclosure aims to provide transparency, manage market expectations, a...
Read Analysis
🤖 AI Generated
OPGEN INC
8-K January 16, 2026

Key Highlights

  • OPGEN is making a bold strategic move by acquiring iCapX Sdn. Bhd., propelling i...
  • This acquisition marks a substantial strategic pivot, diversifying OPGEN from it...
  • iCapX has demonstrated immediate revenue generation potential by securing an est...
Read Analysis
🤖 AI Generated
SemiLEDs Corp
8-K January 16, 2026

Key Highlights

  • SemiLEDs Corp. extended maturity dates for two key loans (Simplot Taiwan Inc. an...
  • Accrued and unpaid interest totaling $364,924.63 on the Simplot Taiwan Inc. loan...
  • These are the seventh extension for the Simplot loan and the eighth for the CEO'...
Read Analysis
🤖 AI Generated
Quanex Building Products CORP
8-K January 16, 2026

Key Highlights

  • Quanex has engaged KPMG LLP, bringing fresh expertise to strengthen financial re...
  • The company confirmed no disagreements with the former auditor on accounting pri...
  • No restatements of past financial statements have occurred despite the identifie...
Read Analysis
🤖 AI Generated
Arbutus Biopharma Corp
8-K January 16, 2026

Key Highlights

  • The European patent revocation is limited to Europe and does not affect Arbutus'...
  • Arbutus maintains a broader, diversified intellectual property strategy across v...
  • The company plans to initiate an appeal process for the revocation.
Read Analysis
🤖 AI Generated
American Resources Corp
8-K January 16, 2026

Key Highlights

  • Company states delay was due to 'administrative oversight' and not shareholder/b...
  • No immediate material financial impact directly from receiving the non-complianc...
  • American Resources Corp has begun scheduling the meeting and expects to meet all...
Read Analysis
🤖 AI Generated
Livento Group, Inc.
8-K January 16, 2026

Key Highlights

  • Fractional shares resulting from the split will be rounded up to the nearest who...
  • Company is changing its trading symbol from NUGN to LIVG and will receive a new ...
  • Aims to increase stock price per share, improve market perception, and attract i...
Read Analysis
🤖 AI Generated
Autonomix Medical, Inc.
8-K January 16, 2026

Key Highlights

  • Successful completion of pivotal Phase 3 clinical trial for NeuroSense device, s...
  • NeuroSense is an innovative, non-invasive diagnostic tool for early-stage neurol...
  • Potential to access a multi-billion dollar global market for early neurological ...
Read Analysis
🤖 AI Generated
NRX Pharmaceuticals, Inc.
8-K January 16, 2026

Key Highlights

  • No immediate impact on the trading of NRX Pharmaceuticals' common stock (NRXP) o...
  • The company has proactively scheduled its 2025 Annual Meeting for March 23, 2026...
  • Scheduling the meeting is a critical step toward resolving the non-compliance wi...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage